Primary Job Title Venture Partner Primary Organization Arboretum Ventures
Location Detroit, Michigan, United States Regions Greater Detroit Area, Great Lakes, Midwestern US Gender Male
Investor Type
LinkedIn View on LinkedIn
George Dunbar joined Arboretum Ventures in 2010 as a Venture Partner. George utilizes his extensive healthcare operating experience as the former CEO of a number of venture-backed healthcare companies to evaluate new investment opportunities in diagnostics, life science tools, and medical devices. George currently serves as the Executive Chairman
of the Board of Directors at CerviLenz and serves on the boards of directors for KFx Medical and IntelliCyt Corporation.
Prior to joining Arboretum, George was the President, CEO, and Chairman of Aastrom Biosciences [NASDAQ: ASTM], a clinical development stage healthcare company based in Ann Arbor, Michigan. Prior to Aastrom, George worked with several national venture capital firms, serving as the CEO of early-stage life sciences companies, including Quantum Dot (acquired by Invitrogen) and Epic Therapeutics (acquired by Baxter Healthcare).
